These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23572296)

  • 21. Androgens and estrogens stimulate ribosome biogenesis in prostate and breast cancer cells in receptor dependent manner.
    Ray S; Johnston R; Campbell DC; Nugent S; McDade SS; Waugh D; Panov KI
    Gene; 2013 Aug; 526(1):46-53. PubMed ID: 23608168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In situ levels of oestrogen producing enzymes and its prognostic significance in postmenopausal breast cancer patients.
    Licznerska BE; Wegman PP; Nordenskjöld B; Wingren S
    Breast Cancer Res Treat; 2008 Nov; 112(1):15-23. PubMed ID: 18030614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgens in human breast carcinoma.
    Suzuki T; Miki Y; Takagi K; Hirakawa H; Moriya T; Ohuchi N; Sasano H
    Med Mol Morphol; 2010 Jun; 43(2):75-81. PubMed ID: 20683693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer.
    Pietri E; Massa I; Bravaccini S; Ravaioli S; Tumedei MM; Petracci E; Donati C; Schirone A; Piacentini F; Gianni L; Nicolini M; Campadelli E; Gennari A; Saba A; Campi B; Valmorri L; Andreis D; Fabbri F; Amadori D; Rocca A
    Oncologist; 2019 Jun; 24(6):743-e205. PubMed ID: 30591548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of androgen excess in the development of estrogen receptor-positive and estrogen receptor-negative breast cancer.
    Secreto G; Zumoff B
    Anticancer Res; 2012 Aug; 32(8):3223-8. PubMed ID: 22843896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity.
    Lin Fde M; Pincerato KM; Bacchi CE; Baracat EC; Carvalho FM
    J Clin Pathol; 2012 Jan; 65(1):64-8. PubMed ID: 22039288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgens and androgen receptor: do they play a role in breast cancer?
    Bryś M
    Med Sci Monit; 2000; 6(2):433-8. PubMed ID: 11208351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher expression of androgen receptor is a significant predictor for better endocrine-responsiveness in estrogen receptor-positive breast cancers.
    Park S; Park HS; Koo JS; Yang WI; Kim SI; Park BW
    Breast Cancer Res Treat; 2012 May; 133(1):311-20. PubMed ID: 22231421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are all aromatase inhibitors alike?
    Blackwell KL
    Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():35-43. PubMed ID: 19101793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole.
    Macedo LF; Guo Z; Tilghman SL; Sabnis GJ; Qiu Y; Brodie A
    Cancer Res; 2006 Aug; 66(15):7775-82. PubMed ID: 16885381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conjugated and non-conjugated androgens differentially modulate specific early gene transcription in breast cancer in a cell-specific manner.
    Notas G; Pelekanou V; Castanas E; Kampa M
    Steroids; 2010; 75(8-9):611-8. PubMed ID: 19857505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen.
    Doane AS; Danso M; Lal P; Donaton M; Zhang L; Hudis C; Gerald WL
    Oncogene; 2006 Jun; 25(28):3994-4008. PubMed ID: 16491124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Over expression of aromatase protein is highly related to MMPs levels in human breast carcinomas.
    Di GH; Lu JS; Song CG; Li HC; Shen ZZ; Shao ZM
    J Exp Clin Cancer Res; 2005 Dec; 24(4):601-7. PubMed ID: 16471323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgen receptors and serum testosterone levels identify different subsets of postmenopausal breast cancers.
    Secreto G; Venturelli E; Meneghini E; Carcangiu ML; Paolini B; Agresti R; Pellitteri C; Berrino F; Gion M; Cogliati P; Saragò G; Micheli A
    BMC Cancer; 2012 Dec; 12():599. PubMed ID: 23241075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The interplay of endocrine therapy, steroid pathways and therapeutic resistance: Importance of androgen in breast carcinoma.
    Takagi K; Miki Y; Ishida T; Sasano H; Suzuki T
    Mol Cell Endocrinol; 2018 May; 466():31-37. PubMed ID: 28918115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate.
    Buchanan G; Birrell SN; Peters AA; Bianco-Miotto T; Ramsay K; Cops EJ; Yang M; Harris JM; Simila HA; Moore NL; Bentel JM; Ricciardelli C; Horsfall DJ; Butler LM; Tilley WD
    Cancer Res; 2005 Sep; 65(18):8487-96. PubMed ID: 16166329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.
    Winer EP; Hudis C; Burstein HJ; Wolff AC; Pritchard KI; Ingle JN; Chlebowski RT; Gelber R; Edge SB; Gralow J; Cobleigh MA; Mamounas EP; Goldstein LJ; Whelan TJ; Powles TJ; Bryant J; Perkins C; Perotti J; Braun S; Langer AS; Browman GP; Somerfield MR
    J Clin Oncol; 2005 Jan; 23(3):619-29. PubMed ID: 15545664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen and androgen repression of two female specific lacrimal lipocalins in hamster: Pituitary independent and sex hormone receptor mediated action.
    Srikantan S; Paliwal A; Quintanar-Stephano A; De PK
    Gen Comp Endocrinol; 2007 Apr; 151(2):172-9. PubMed ID: 17316636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.